US FDA approves Outlook Therapeutics' eye disease drug - Reuters
US FDA approves Outlook Therapeutics' eye disease drug Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZnYzcnRTMTJUYTdfQnFVQ1AtaUR1X1NYMXRaWHh3b2NwbnVvYXp0WVdGLXBEN1JkSW1IZXRFQXpMbWlZeTNiLXdQZ2NNQVZFQk9rTmE5d3UtejhzOEVDaGFKU1o0Mnk2TXNzakJfSTBDNHlWYk9fUXJIaXdnVHhqMXNnV2gzRzJJcXdBOVhoVnd1R3dyWF9BUlZHUi1rUTl2bUlDU2d4c1Rudw?oc=5" target="_blank">US FDA approves Outlook Therapeutics' eye disease drug</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
August 17, 2026 at 03:45 PMUS FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PMUS FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMUltragenyx's gene therapy wins first FDA approval for rare metabolic disorder - Reuters
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder Reuters
August 19, 2026 at 10:36 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PM